January
11
Exagen Inc. Announces Select Preliminary 2025 Financial Results
CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing,...
News
Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.